InsiderPulse| Trade Date | Filed | Owner | Role | Type | Shares | Price | Value | Owned After | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-06 | 2026-04-07 | McLaughlin Melissa | Chief Human Resources Officer | Sale | 2,286 | $330.42 | $755K | 9,443 | View ↗ | |
| 2026-04-02 | 2026-04-07 | McLaughlin Melissa | Chief Human Resources Officer | Sale | 1,624 | $319.59 | $519K | 11.7K | View ↗ | |
| 2026-03-05 | 2026-03-06 | Garg Pushkal | EVP Chief R&D | Sale | 2,404 | $323.96 | $779K | 18.7K | View ↗ | |
| 2026-03-05 | 2026-03-06 | Fitzgerald Kevin Joseph | CSO & EVP, Head of Research | Sale | 658 | $323.98 | $213K | 20.6K | View ↗ | |
| 2026-03-04 | 2026-03-06 | Garg Pushkal | EVP Chief R&D | Sale | 2,309 | $323.08 | $746K | 21.1K | View ↗ |
| Date | Member | Chamber | Type | Amount |
|---|---|---|---|---|
| 2025-05-12 | Jefferson Shreve(R-IN06) | house | Sale | $15,001 - $50,000 |
| 2024-01-29 | Josh Gottheimer(D-NJ05) | house | Sale | $1,001 - $15,000 |
| 2024-01-11 | Josh Gottheimer(D-NJ05) | house | Purchase | $1,001 - $15,000 |
| 2023-12-11 | Josh Gottheimer(D-NJ05) | house | Sale | $1,001 - $15,000 |
| 2022-09-28 | Josh Gottheimer(D-NJ05) | house | Purchase | $1,001 - $15,000 |
No annual data found.
Tenaya Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
Alnylam to Present New Analyses at Heart Failure 2026 Underscoring Consistent Clinical Profile of Vutrisiran in ATTR-CM
Alnylam Pharmaceuticals, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
Extreme Networks And 2 Additional Stocks Estimated To Be Trading Below Their Fair Value